首页> 外文期刊>High-Throughput >New Challenges for Biobanks: Accreditation to the New ISO 20387:2018 Standard Specific for Biobanks
【24h】

New Challenges for Biobanks: Accreditation to the New ISO 20387:2018 Standard Specific for Biobanks

机译:Biobanks的新挑战:对新ISO的认证20387:2018年生物人数的标准

获取原文
       

摘要

Background: The emergence of “multi-omics” and “multi-parametric” types of analysis based on a high number of biospecimens enforces the use of a great number of high-quality “Biological Materials and Associated Data” (BMaD). To meet the demands of biomedical research, several Biological Resource Centers (BRCs) or Biobanks world-wide have implemented a specific Quality Management System (QMS) certified ISO 9001:2015 or accredited by CAP9 ISO 20387:2018. For the first time, ISO, with the support of several Biobanking experts, issued the ISO 20387:2018 which is the first ISO norm specific for Biobanks. The fundamental difference with present certification/accreditation standards is that the ISO 20387:2018 focuses not only on the operational aspects of the Biobank, but also on the “competence of the Biobank to carry our specific Biobanking tasks”. Methods: The accreditation process for ISO 20387:2018 required the definition of: (1) objectives, goals and organizational structure of the Biobank, including procedures for governance, confidentiality and impartiality policies; (2) standard operating procedures (SOPs) of all activities performed, including acquisition, analysis, collection, data management, distribution, preparation, preservation, testing facility and equipment maintenance, calibration, and monitoring; (3) procedures for control of documents and records, the identification of risks and opportunities, improvements, corrective actions, nonconforming records and evaluation of external providers (4) an internal audit and management reviews, verification of QMS performance, monitoring of quality objectives and personnel qualification and competency in carrying out specific Biobanking tasks. Results: The accreditation process is performed by an independent authorized organization which certifies that all processes are performed according to the QMS, and that the infrastructure is engineered and managed according to the GDP and/or GMP guidelines. Conclusion: Accreditation is given by an accreditation body, which recognizes formally that the Biobank is “competent to carry out specific Biobanking tasks”.
机译:背景:基于大量的生物开发的“多ommics”的出现和“多参数”类型的分析强制使用大量的高质量“生物材料和相关数据”(BMAD)。为满足生物医学研究的需求,全球若干生物资源中心(BRC)或BioBanks已经实施了特定的质量管理体系(QMS)认证ISO 9001:2015或由CAP9 ISO 20387:2018认证。通过支持若干生物管理专家的支持,ISO首次发布了ISO 20387:2018,这是对BioBanks的第一个ISO规范。目前认证/认证标准的根本差异是ISO 20387:2018不仅关注生物人物的运营方面,而且侧重于“生物人物的能力,以携带我们的特定生物管理任务”。方法:ISO 20387:2018的认证过程需要定义:(1)生物人物的目标,目标和组织结构,包括治理,保密和公正政策的程序; (2)所有活动的标准操作程序(SOP),包括采集,分析,收集,数据管理,分销,准备,保存,测试设施和设备维护,校准和监控; (3)控制文件和记录的程序,确定风险和机遇,改进,纠正措施,不合格记录和外部提供者的评估(4)内部审计和管理评审,核查QMS绩效,质量监测执行特定的生物管理任务的人员资格和能力。结果:认证过程由一个独立的授权组织执行,该组织认证,根据QMS进行所有进程,并且基础架构根据GDP和/或GMP指南设计和管理。结论:认证由认证机构提供,这正式承认,BioBank是“有能力进行特定的生物管理任务”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号